Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - COMMON STOCK
Common Stock RARE - Ultragenyx Pharmaceutical Inc.
82 K
LAST VALUE
9.01%
2 YEAR CAGR
9.96%
5 YEAR CAGR
35.26%
10 YEAR CAGR